IL231820A0 - Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors - Google Patents
Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitorsInfo
- Publication number
- IL231820A0 IL231820A0 IL231820A IL23182014A IL231820A0 IL 231820 A0 IL231820 A0 IL 231820A0 IL 231820 A IL231820 A IL 231820A IL 23182014 A IL23182014 A IL 23182014A IL 231820 A0 IL231820 A0 IL 231820A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- phosphodiesterase type
- systematic use
- redness associated
- facial redness
- Prior art date
Links
- 230000001815 facial effect Effects 0.000 title 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 title 1
- 230000009897 systematic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161548844P | 2011-10-19 | 2011-10-19 | |
| PCT/IB2012/002500 WO2013057579A2 (en) | 2011-10-19 | 2012-10-12 | Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL231820A0 true IL231820A0 (en) | 2014-05-28 |
Family
ID=47631462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL231820A IL231820A0 (en) | 2011-10-19 | 2014-03-31 | Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9744168B2 (enExample) |
| EP (1) | EP2768502A2 (enExample) |
| JP (1) | JP2014530846A (enExample) |
| KR (1) | KR20140091543A (enExample) |
| CN (1) | CN103889417A (enExample) |
| AU (1) | AU2012324543B2 (enExample) |
| BR (1) | BR112014009210A2 (enExample) |
| CA (1) | CA2850273A1 (enExample) |
| IL (1) | IL231820A0 (enExample) |
| MX (1) | MX2014004383A (enExample) |
| PH (1) | PH12014500783A1 (enExample) |
| RU (1) | RU2014119879A (enExample) |
| WO (1) | WO2013057579A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120076738A1 (en) * | 2010-09-28 | 2012-03-29 | Michael Graeber | Combination treatment for dermatological conditions |
| WO2015191917A1 (en) * | 2014-06-11 | 2015-12-17 | Allergan, Inc. | Stabilized oxymetazoline formulations and their uses |
| WO2018065546A1 (en) * | 2016-10-07 | 2018-04-12 | Micreos Human Health B.V. | Vasoconstricitve and antibacterial combination treatment for rosacea |
| KR102122980B1 (ko) * | 2018-12-28 | 2020-06-18 | 한국프라임제약주식회사 | 들깨 잎 추출물을 유효성분으로 함유하는 갱년기 관련 안면홍조 완화용 조성물 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3278447A (en) | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
| DE2436882A1 (de) | 1974-07-29 | 1976-02-19 | Schering Ag | Neue oxyphenylbutazon-derivate und ihre herstellung |
| DE2436883C2 (de) | 1974-07-29 | 1985-08-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| DE2632678C2 (de) | 1976-07-16 | 1986-02-27 | Schering AG, 1000 Berlin und 4709 Bergkamen | 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung |
| NZ185295A (en) | 1976-10-04 | 1980-04-28 | Schering Ag | 9-chloroprednisolone derivatives and pharmaceutical compositions |
| US4285967A (en) | 1978-06-30 | 1981-08-25 | Estee Lauder Inc. | Cosmetic preparation for reducing redness of blemishes |
| US4908387A (en) | 1988-06-06 | 1990-03-13 | The Regents Of The University Of California | Use of beta2 antagonists in the treatment of inflammatory diseases, in particular, rheumatoid arthritis |
| CA2003198C (en) | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5736165A (en) | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
| ES2187533T3 (es) | 1993-10-13 | 2003-06-16 | Allergan Inc | Usdo de derivados de (2-imidazolin-2-ilamino)quinoxalina. |
| US6117871A (en) | 1993-12-17 | 2000-09-12 | The Procter & Gamble Company | 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| WO2000023066A2 (en) | 1998-10-20 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| CA2154979A1 (en) | 1995-07-28 | 1997-01-29 | Kenneth T. Armstrong | Topical phenylephrine preparation |
| US5910312A (en) | 1996-10-09 | 1999-06-08 | Ideal Ideas, Inc. | Acne treatment composition with vasoconstrictor |
| SE9901295D0 (sv) | 1999-04-13 | 1999-04-13 | Jan Hedner | Sätt och medel för att förebygga, behandla och diagnostisera kardiovaskulära komplikationer hos patienter med obstruktiv sömnapné |
| ES2199094T1 (es) | 1999-08-19 | 2004-02-16 | Lavipharm Sa | Polimeros formadores de pelicula, procedimientos de uso y aplicaciones de los mismos. |
| US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
| CA2402405C (en) | 2000-07-14 | 2008-02-12 | Allergan Sales, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| US6680062B2 (en) | 2001-10-05 | 2004-01-20 | Color Access, Inc. | Anti-irritating rosacea treatment |
| US7345065B2 (en) | 2002-05-21 | 2008-03-18 | Allergan, Inc. | Methods and compositions for alleviating pain |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
| US20050020600A1 (en) * | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| US7812049B2 (en) * | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| CA2567401C (en) * | 2004-05-25 | 2013-11-12 | Sansrosa Pharmaceutical Development, Inc. | Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
| US20090061020A1 (en) | 2007-08-31 | 2009-03-05 | Theobald Klaus P | Brimonidine Compositions for Treating Erythema |
| EP2230910A4 (en) | 2007-12-21 | 2011-04-13 | Galderma Lab Inc | PRE-SURGICAL TREATMENT |
| KR20110017365A (ko) | 2008-05-30 | 2011-02-21 | 페어필드 클리니컬 트라이얼즈 엘엘씨 | 피부 염증 및 변색을 위한 방법 및 조성물 |
| WO2009152344A2 (en) * | 2008-06-11 | 2009-12-17 | Comgenrx, Inc. | Combination therapy using phosphodiesterase inhibitors |
| EP2493475A4 (en) | 2009-10-30 | 2014-10-29 | Intratus Inc | COSMETIC METHODS AND PREPARATIONS FOR THE PROLONGED RELEASE OF THERAPEUTIC AGENTS IN THE EYE |
| MX2012010824A (es) | 2010-03-26 | 2012-10-10 | Galderma Res & Dev | Metodos y composiciones mejoradas para tratamiento seguro y efectivo del eritema. |
-
2012
- 2012-10-12 BR BR112014009210A patent/BR112014009210A2/pt not_active IP Right Cessation
- 2012-10-12 CA CA2850273A patent/CA2850273A1/en not_active Abandoned
- 2012-10-12 WO PCT/IB2012/002500 patent/WO2013057579A2/en not_active Ceased
- 2012-10-12 PH PH1/2014/500783A patent/PH12014500783A1/en unknown
- 2012-10-12 CN CN201280051534.6A patent/CN103889417A/zh active Pending
- 2012-10-12 KR KR1020147011912A patent/KR20140091543A/ko not_active Withdrawn
- 2012-10-12 AU AU2012324543A patent/AU2012324543B2/en not_active Expired - Fee Related
- 2012-10-12 JP JP2014536349A patent/JP2014530846A/ja active Pending
- 2012-10-12 US US14/344,099 patent/US9744168B2/en not_active Expired - Fee Related
- 2012-10-12 EP EP12821025.9A patent/EP2768502A2/en not_active Withdrawn
- 2012-10-12 MX MX2014004383A patent/MX2014004383A/es unknown
- 2012-10-12 RU RU2014119879/15A patent/RU2014119879A/ru not_active Application Discontinuation
-
2014
- 2014-03-31 IL IL231820A patent/IL231820A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140343067A1 (en) | 2014-11-20 |
| RU2014119879A (ru) | 2015-11-27 |
| AU2012324543B2 (en) | 2017-08-10 |
| WO2013057579A2 (en) | 2013-04-25 |
| AU2012324543A1 (en) | 2014-05-01 |
| EP2768502A2 (en) | 2014-08-27 |
| PH12014500783A1 (en) | 2014-05-12 |
| WO2013057579A3 (en) | 2013-07-04 |
| JP2014530846A (ja) | 2014-11-20 |
| KR20140091543A (ko) | 2014-07-21 |
| MX2014004383A (es) | 2014-11-12 |
| CN103889417A (zh) | 2014-06-25 |
| CA2850273A1 (en) | 2013-04-25 |
| US9744168B2 (en) | 2017-08-29 |
| BR112014009210A2 (pt) | 2017-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2710007T3 (da) | Kinasehæmmere | |
| DK3542843T3 (da) | Engangsinjektionspen til flere anvendelser | |
| PL3579556T3 (pl) | Sposób generowania bloku kwantowanego | |
| DK2685986T3 (da) | Glucosylceramidsyntasehæmmer | |
| BR112013029474A2 (pt) | ferramenta multi-abrasiva | |
| HRP20190135T1 (hr) | 4-imidazopiridazin-1-yl-benzamidi i 4-imidazotriazin-1-yl-benzamidi kao inhibitori btk | |
| EP2729895A4 (en) | Syntactical fingerprinting | |
| EP2734939A4 (en) | METHOD FOR SOCIAL RESEARCH | |
| DK3117861T3 (da) | Grænseflade omfattende en rullende næsebrodel | |
| HUE047421T2 (hu) | Nanoréteg bevonat nagyteljesítményû szerszámokhoz | |
| DK2734740T3 (da) | Skruehoved | |
| HRP20160134T1 (hr) | Spojevi triazolopiridina kao inhibitori pim kinaze | |
| IL228567A0 (en) | Imidazopyridazines as akt kinase inhibitors | |
| EP2740420A4 (en) | THERAPEUTIC DEVICE | |
| LT2985998T (lt) | Laikmena koduotų vaizdo duomenų laikymui | |
| DK2707101T3 (da) | Proteostaseregulatorer | |
| DE112012000934T8 (de) | Schraubenschlüssel-Werkzeug | |
| SI2691934T1 (sl) | Baza podatkov fotorobotov (3D) | |
| DK2564995T3 (da) | Værktøj | |
| GB201120314D0 (en) | Secure database searching | |
| BRDI7103766S (pt) | Configuração aplicada em ferramenta | |
| FI20115336A0 (fi) | Suihkutuspää | |
| IL231820A0 (en) | Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors | |
| FR2974322B1 (fr) | Robot d'usinage | |
| EP2770998A4 (en) | Factor ixa inhibitors |